After Two Successful Years, We’re Planning Further Growth
We’re excited to announce that after celebrating our second year of business, we’re gearing up for additional multi-million-pound growth as we continue to evolve and expand beyond COVID.
Back in 2020 our core focus was COVID PCR, antigen analysis, and the associated complexities of international travel.
Since then, we’ve grown our service offering and are now focussing on the delivery of fully managed health services on an international basis covering all aspects of occupational health, as well as corporate health and wellbeing.
Service and location growth
Our services include (but are not limited to), drug and alcohol consultancy and screening, travel health and wellbeing, health risk assessment and health surveillance. Along with a full scope of work related and executive medicals, workplace immunisation and absence management support.
We’ve also grown our presence in both Aberdeen and Teesside, following the acquisition of RelyOn Nutec’s occupational health division and clinics earlier this year.
With a team of 15 and an additional 25 expert associates covering clinical governance, additional healthcare delivery, UKAS/ISO accreditation, legal and HR, this level of expertise ensures that our full team are compliant over and above local, national and international requirements.
Our plans for year four and five include doubling in size, with acquisitions in the private healthcare, business service, and laboratory markets.
We’ve recently signed 12 new business client contracts in the corporate health and wellbeing space and the pipeline of new customers growing daily. A further six potential tender response opportunities are also being targeted in the oil & gas, maritime, renewables, chemical, and manufacturing industries.
Mike Eriksen, Agilis Health Chief Executive, said: “We are on target to achieve our planned profile switch to 80% business to business customers which is a move away from the retail, transactional focus during COVID, replacing this with long term commercial contract revenues. With a strong pipeline in the coming months and plans to complete more acquisitions, we are looking at internationalisation of our managed corporate health service across Mexico, Brazil, and the Middle East to support our client requirements.
“The first two years of the business has seen us evolve at pace, we’re now right where we should be, on target with our initial plan and expansion goals. The future growth and strength of the business is incredibly exciting as we develop and deliver our managed service expertise across the UK and internationally, adding real value to SMEs and multinational corporates in a variety of industries, as well as supporting the oil and gas industry with the energy transition.”
Growth in the pharmacy sector
We’re also set to grow our pharmacy network across the UK. We offer a unique wellbeing access point that enables pharmacies to offer our health assessments, blood tests, COVID tests and other services to the consumer market.
Want to learn more?
If you’d like to know more about our plans for the future or our range of services, don’t hesitate to get in touch!